PR-AIR: A program to reduce pediatric asthma disparities in Puerto Rico
Official title: Puerto Rico Asthma Integrated Response Program (PR-AIR)
Funded at Rhode Island Hospital · NIH-11418024 · Data updated 2026-11-12
Aimed at Puerto Rican children with asthma, this project tests home and school–based strategies to reduce asthma burden in San Juan through community involvement and tailored implementation.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project start | September 15, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $692,502 |
| NIH project number | 5R01HL159701-05 |
| Project ID | NIH-11418024 on NIH RePORTER |
Who could benefit from this research
✓Could help
Children with asthma living in San Juan, PR, and their families, plus school staff and healthcare providers engaged in their care.
✕Less likely to help
Families not in the participating 12 high-burden communities may not directly benefit during the study.
What this research studies
This funded project partners with families, schools, and healthcare providers in San Juan to adapt proven asthma interventions for Puerto Rico. It uses a phased approach, beginning with community input and interviews to tailor methods, followed by a hybrid effectiveness-implementation trial comparing virtual and in-person delivery. The study will roll out the program sequentially to 12 high-burden communities using a cluster-randomized stepped-wedge design. The goal is to improve asthma management and outcomes by improving home, school, and clinician communication and by identifying barriers and facilitators to real-world uptake. Participation would involve families, caregivers, school staff, and healthcare teams across participating communities.
Why it matters
Potential benefit: If successful, PR-AIR could reduce asthma symptoms and healthcare visits for Puerto Rican children through better home-school-clinic coordination.
How similar studies have gone: Previous similar implementation efforts in other communities show promise for improving management when interventions are adapted to local contexts.
Where this research is happening
-
Rhode Island Hospital
Providence, United States Active
Researchers
- Principal investigator: Koinis Mitchell, Daphne — Rhode Island Hospital
- Study coordinator: Koinis Mitchell, Daphne
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.